| 000 | 01509 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250516030222.0 | ||
| 264 | 0 | _c20110721 | |
| 008 | 201107s 0 0 eng d | ||
| 022 | _a1860-7187 | ||
| 024 | 7 |
_a10.1002/cmdc.201100047 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKeil, Stefanie | |
| 245 | 0 | 0 |
_aSulfonylthiadiazoles with an unusual binding mode as partial dual peroxisome proliferator-activated receptor (PPAR) γ/δ agonists with high potency and in vivo efficacy. _h[electronic resource] |
| 260 |
_bChemMedChem _cApr 2011 |
||
| 300 |
_a633-53 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBinding Sites |
| 650 | 0 | 4 | _aCrystallography, X-Ray |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Experimental _xdrug therapy |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xdrug therapy |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aPPAR delta _xagonists |
| 650 | 0 | 4 |
_aPPAR gamma _xagonists |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 |
_aSulfones _xagonists |
| 650 | 0 | 4 |
_aThiadiazoles _xagonists |
| 700 | 1 | _aMatter, Hans | |
| 700 | 1 | _aSchönafinger, Karl | |
| 700 | 1 | _aGlien, Maike | |
| 700 | 1 | _aMathieu, Magali | |
| 700 | 1 | _aMarquette, Jean-Pierre | |
| 700 | 1 | _aMichot, Nadine | |
| 700 | 1 | _aHaag-Diergarten, Silke | |
| 700 | 1 | _aUrmann, Matthias | |
| 700 | 1 | _aWendler, Wolfgang | |
| 773 | 0 |
_tChemMedChem _gvol. 6 _gno. 4 _gp. 633-53 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/cmdc.201100047 _zAvailable from publisher's website |
| 999 |
_c20672032 _d20672032 |
||